Journal of Clinical Oncology

Reply to: Optimizing Allogeneic Chimeric Antigen Receptor T-Cell Persistence in Relapsed/Refractory Large B-Cell Lymphoma: The Role of KIR Matching

F Frederick L. Locke J John B. Le Gall (17Allogene Therapeutics, San Francisco, United States) P Paul W. Fisher (Frederick L. Locke, MD, Moffitt Cancer Center and Research Institute, Tampa, FL; John B. Le Gall, MD, MBA and Paul W. Fisher, PhD, Allogene Therapeutics, San Francisco, CA; and Sattva S. Neelapu, MD, The University of Texas MD Anderson Cancer Center, Houston, TX) S Sattva S. Neelapu
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 25
Published September 01, 2025
Pages 2834-2835
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (4)

F

Frederick L. Locke

J

John B. Le Gall

17Allogene Therapeutics, San Francisco, United States

P

Paul W. Fisher

Frederick L. Locke, MD, Moffitt Cancer Center and Research Institute, Tampa, FL; John B. Le Gall, MD, MBA and Paul W. Fisher, PhD, Allogene Therapeutics, San Francisco, CA; and Sattva S. Neelapu, MD, The University of Texas MD Anderson Cancer Center, Houston, TX

S

Sattva S. Neelapu

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001